Filing Details
- Accession Number:
- 0001209191-13-057852
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-18 19:30:03
- Reporting Period:
- 2013-12-17
- Filing Date:
- 2013-12-18
- Accepted Time:
- 2013-12-18 19:30:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
949699 | Pharmacyclics Inc | PCYC | Pharmaceutical Preparations (2834) | 943148201 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1507649 | Gregory Hemmi | C/O Pharmacyclics, Inc. 995 East Arques Avenue Sunnyvale CA 94085 | Vp Chemical Operations | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-12-17 | 10,000 | $0.86 | 35,004 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-12-17 | 10,000 | $102.00 | 25,004 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-12-18 | 10,000 | $0.86 | 35,004 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-12-18 | 10,000 | $99.04 | 25,004 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2013-12-17 | 10,000 | $0.00 | 10,000 | $0.86 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2013-12-18 | 10,000 | $0.00 | 10,000 | $0.86 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
113,515 | 2008-03-18 | 2018-03-18 | No | 4 | M | Direct |
103,515 | 2008-03-18 | 2018-03-18 | No | 4 | M | Direct |
Footnotes
- Option granted under the issuer's 2004 Equity Incentive Award Plan in a transaction exempt under rule 16b-3(d). Option shares are fully vested.